Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Primary Minimal Change Nephropathy: A Randomized Open-labeled Non-inferiority Study on Prednisolone and Vitamin D

NCT03210688 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT03210688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03210688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Primary Minimal Change Nephropathy: A Randomized Open-labeled Non-inferiority Study on Prednisolone and Vitamin D
Lead sponsor
University of Aarhus
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2018
Completion date
January 21, 2025
Enrollment
71 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

minimal change disease, nephrotic syndrome